Ancilia Bio
Drug Discovery
Ancilia Bio valuation and funding history | Last updated: April 1, 2023 | 1 funding rounds
Current Valuation
N/A
As of April 1, 2023
Total Funding Raised
N/A
Across 1 round
Last Round
Early Stage VC
Amount undisclosed
Last Funding
Apr 2023
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| April 1, 2023 | Early Stage VC | Undisclosed | N/A | - |
Valuation Analysis
Current Valuation Metrics
Ancilia Bio is currently valued at N/A as of April 1, 2023.
What is Ancilia Bio Worth in 2026?
Ancilia Bio is a leading private company in the Drug Discovery sector. Track Ancilia Bio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Ancilia Bio Valuation is Determined
Private company valuations like Ancilia Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.